On Mar 9, 2022 Fluent BioSciences closed a Grant round and raised $1,700,000 from Small Business Innovation Research, featuring lead investors Small Business Innovation Research. […]
Abcore acquired by Fortis Life Sciences
Mar 2, 2022 Fortis Life Sciences has entered into an agreement to acquire Abcore . Fortis Life Sciences based at Waltham, Massachusetts, United States. ” […]
Series A – Mycorena
On Mar 2, 2022 Mycorena closed a Series A round and raised €24,000,000 from investors, featuring lead investors . About the company: Mycorena is located […]
Post-IPO Equity – Hookipa Pharma
On Mar 2, 2022 Hookipa Pharma closed a Post-IPO Equity round and raised $75,000,000 from investors, featuring lead investors . About the company: Hookipa Pharma […]
Post-IPO Debt – Bio-Rad Laboratories
On Mar 2, 2022 Bio-Rad Laboratories closed a Post-IPO Debt round and raised $1,200,000,000 from investors, featuring lead investors . About the company: Bio-Rad Laboratories […]
Series B – Epsilogen
On Mar 2, 2022 Epsilogen closed a Series B round and raised £30,750,000 from 3B Future Health Fund, ALSA Ventures, British Patient Capital, Caribou Property, […]
Series A – Alimetry
On Mar 2, 2022 Alimetry closed a Series A round and raised $16,300,000 from IP Group, K1W1, Matū Fund, Movac, Uniservices, featuring lead investors Movac. […]
Series A – Rondo Therapeutics
On Mar 2, 2022 Rondo Therapeutics closed a Series A round and raised $67,000,000 from Canaan Partners, Johnson & Johnson Innovation – JJDC, Novo Holdings, […]
Post-IPO Debt – Bio-Rad Laboratories
On Mar 2, 2022 Bio-Rad Laboratories closed a Post-IPO Debt round and raised $1,200,000,000 from investors, featuring lead investors . About the company: Bio-Rad Laboratories […]
Series A – Alimetry
On Mar 2, 2022 Alimetry closed a Series A round and raised $16,300,000 from IP Group, K1W1, Matū Fund, Movac, Uniservices, featuring lead investors Movac. […]
